Intellia Therapeutics Inc (NASDAQ:NTLA)
| 117.25 Delayed Data As of Dec 07 |  +16.49 / +16.37%Today’s Change | 43.86 Today|||52-Week Range 202.73 | +115.53% Year-to-Date |
Institutional investors purchased a net $3.3 million shares of NTLA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 81.70% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Mutual fund holders | 52.72% |
| Other institutional | 28.98% |
| Individual stakeholders | 22.44% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 10/31/2021 | ARK INVESTMENT MANAGEMENT LLC Bought 898.9 Thousand shares of Intellia Therapeutics Inc |
| 9/30/2021 | MORGAN STANLEY INVESTMENT MANAGE... Bought 662.1 Thousand shares of Intellia Therapeutics Inc |
| 9/30/2021 | FRANKLIN ADVISERS, INC. Bought 587.7 Thousand shares of Intellia Therapeutics Inc |
Top 10 Owners of Intellia Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 10.27% | 7,642,452 | 878,958,405 | +898,896 | +13.33% |
| The Vanguard Group, Inc. | 8.28% | 6,160,074 | 708,470,111 | +317,370 | +5.43% |
| BlackRock Fund Advisors | 6.40% | 4,761,640 | 547,636,216 | +395,863 | +9.07% |
| Fidelity Management & Research Co... | 4.25% | 3,164,605 | 363,961,221 | +448,353 | +16.51% |
| Nikko Asset Management Americas, ... | 3.23% | 2,399,933 | 276,016,294 | -663,516 | -21.66% |
| T. Rowe Price Associates, Inc. (I... | 3.15% | 2,344,538 | 269,645,315 | -141,953 | -5.71% |
| SSgA Funds Management, Inc. | 2.23% | 1,661,730 | 191,115,567 | -116,612 | -6.56% |
| Viking Global Investors LP | 1.72% | 1,279,531 | 147,158,860 | +304,439 | +31.22% |
| AllianceBernstein LP | 1.66% | 1,236,904 | 142,256,329 | +27,436 | +2.27% |
| Geode Capital Management LLC | 1.61% | 1,197,090 | 137,677,321 | +78,310 | +7.00% |
Top 10 Mutual Funds Holding Intellia Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| ARK Innovation ETF | 6.48% | 4,821,228 | 554,489,432 | -26,424 | -0.55% |
| Nikko AM Global Umbrella Fund - A... | 3.20% | 2,377,527 | 273,439,380 | -1,659,603 | -41.11% |
| Vanguard Total Stock Market Index... | 2.52% | 1,872,628 | 215,370,946 | +1,252 | +0.07% |
| ARK Genomic Revolution ETF | 2.23% | 1,660,557 | 190,980,661 | -8,631 | -0.52% |
| Vanguard Small Cap Index Fund | 2.22% | 1,652,259 | 190,026,308 | +6,214 | +0.38% |
| iShares Russell 2000 ETF | 2.20% | 1,639,252 | 188,530,373 | -260 | -0.02% |
| Vanguard Small Cap Growth Index F... | 1.40% | 1,040,631 | 119,682,971 | +710 | +0.07% |
| Vanguard Extended Market Index Fu... | 1.23% | 914,760 | 105,206,548 | -436 | -0.05% |
| Fidelity Contrafund | 1.15% | 853,685 | 98,182,312 | -12,230 | -1.41% |
| Fidelity Select Port. - Biotechno... | 1.13% | 839,801 | 96,585,513 | 0 | 0.00% |